Related Experiment Video
Updated: Jul 7, 2026

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
Published on: March 28, 2017
Evolved CYP102A1 (P450BM3) variants oxidise a range of non-natural substrates and offer new selectivity options
Christopher J C Whitehouse1, Stephen G Bell, Henry G Tufton
1Department of Chemistry, University of Oxford, Inorganic Chemistry Laboratory, South Parks Road, Oxford, UK OX1 3QR.
Abstract:
The evolution of CYP102A1 variants with enhanced activity and altered specificity characteristics.
More Related Videos
08:02Benchtop Immobilized Metal Affinity Chromatography, Reconstitution and Assay of a Polyhistidine Tagged Metalloenzyme for the Undergraduate Laboratory
Published on: August 23, 2018
09:33Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
Related Concept Videos
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Drug Metabolism: Phase I Reactions
Peroxisomes
Evolution of New Traits in Microbes
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Catalytically Perfect Enzymes